Abstract
A SPE-LC-MS/MS method was developed and validated for the determination of three active pharmaceutical ingredients [API A (3-([2-(diaminomethyleneamino)thiazol-4-yl]methylthio)-N′-sulfamoyl propanimid amide, API B 5-[(2 R)-2-[2-(2-ethoxyphenoxy)ethylamino]propyl]-2-methoxybenzenesulfonamide hydrochloride, API C 1-azabicyclo[2.2.2]octan-8-yl (1S)-1-phenyl-3,4-dihydro-1H-isoquinoline-2-carboxylate] in the wastewater of a chemical synthesis production facility. The SPE-LC-MS/MS method was validated in actual influent and effluent samples. Linearity, LOD, LOQ, repeatability, intermediate precision, and recovery were determined. An LOQ of 400 μg · L−1, 1.0 μg · L−1, and 6 μg · L−1, repeatability of 2.5% CV, 14.8% CV, and 11.9% CV, intermediate precision of 7.8% CV, 11.0% CV, and 8.7% CV and SPE recovery of 114%, 103%, and 91% was determined for API A, B, and C, respectively, in influent. An LOQ of 400 μg · L−1, 0.8 μg · L−1, and 6 μg · L−1, repeatability of 2.0% CV, 11.0% CV, and 10.9% CV, intermediate precision of 1.7% CV, 6.8% CV, and 10.2% CV and SPE recovery of 116%, 96%, and 115% was established for API A, B, and C, respectively, in effluent. Coefficients of correlation for each analyte were >0.9301 confirming the linearity of the method. The LC-MS/MS method was used for an on-going monitoring program for these pharmaceuticals in wastewater. The method development techniques, validation procedures, and results from real wastewater samples are presented in this paper.
Acknowledgments
This research project was financially supported by Science Foundation Ireland (SFI, 07/RFP/EEEOBF768) and Questor Centre (DCU2/07/10).